227 related articles for article (PubMed ID: 6243811)
1. [Prevention of thrombosis by thrombocyte inhibitors. 1. Cell regulation mechanisms and pharmacological modification].
Hansen MS; Birgens HS
Ugeskr Laeger; 1980 Jan; 142(5):303-5. PubMed ID: 6243811
[No Abstract] [Full Text] [Related]
2. [Prevention of thrombosis by thrombocyte inhibition. 2. Clinical results].
Birgens HS; Hansen MS
Ugeskr Laeger; 1980 Jan; 142(5):306-9. PubMed ID: 6986701
[No Abstract] [Full Text] [Related]
3. [Antiplatelet drugs (author's transl)].
Dechavanne M; Follea G; Trzeciak MC
Anesth Analg (Paris); 1979; 36(7-8):283-7. PubMed ID: 525834
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology of platelets.
Packham MA; Mustard JF
Blood; 1977 Oct; 50(4):555-73. PubMed ID: 332253
[No Abstract] [Full Text] [Related]
5. [Platelet-inhibiting drugs].
Jobin F
Union Med Can; 1978 Feb; 107(2):163-6,171-7. PubMed ID: 636101
[No Abstract] [Full Text] [Related]
6. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.
de Gaetano G; Cerletti C; Bertelè V
Lancet; 1982 Oct; 2(8305):974-7. PubMed ID: 6127469
[No Abstract] [Full Text] [Related]
7. Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
Weiss HJ
Am Heart J; 1976 Jul; 92(1):86-102. PubMed ID: 785989
[No Abstract] [Full Text] [Related]
8. The role of prostacyclin and thromboxane A2 in the regulation of platelet behaviour.
Moncada S
Mater Med Pol; 1980; 12(3):207-12. PubMed ID: 7019591
[No Abstract] [Full Text] [Related]
9. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
Oelz O
Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
[TBL] [Abstract][Full Text] [Related]
10. [Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
Jobin F
Union Med Can; 1976 Aug; 105(8):1159-73. PubMed ID: 10662
[No Abstract] [Full Text] [Related]
11. In vitro evaluation of inhibitors of platelet release and aggregation.
Rosenberg JC; Sell TL
Arch Surg; 1975 Aug; 110(8):980-3. PubMed ID: 168838
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet therapy.
Sloan RW
Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet therapy (first of two parts).
Weiss HJ
N Engl J Med; 1978 Jun; 298(24):1344-7. PubMed ID: 651993
[No Abstract] [Full Text] [Related]
14. The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
Arfors KE; Bergqvist D; Tangen O
Acta Chir Scand; 1975; 141(1):40-2. PubMed ID: 1092111
[TBL] [Abstract][Full Text] [Related]
15. [Platelet suppressive drugs (author's transl)].
Shio H; Kameyama M
No Shinkei Geka; 1981 Feb; 9(2):113-22. PubMed ID: 6264335
[No Abstract] [Full Text] [Related]
16. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Turpie AG
Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
[TBL] [Abstract][Full Text] [Related]
17. Platelet release and aggregation induced by antithymocyte globulin. In vitro effect of inhibitors.
Rosenberg JC; Sell T
Transplantation; 1975 Oct; 20(4):346-50. PubMed ID: 169611
[No Abstract] [Full Text] [Related]
18. Roles of cyclic nucleotides in platelet function.
Haslam RJ
Ciba Found Symp; 1975; 35():121-51. PubMed ID: 179765
[No Abstract] [Full Text] [Related]
19. Indobufen, a new inhibitor of platelet aggregation. Studies in guinea pigs.
Bergamaschi M; Ceserani R; Pierucci L; Pogliani E; Spelta A
Pharmacol Res Commun; 1979 Mar; 11(3):279-94. PubMed ID: 461494
[No Abstract] [Full Text] [Related]
20. One, two, three or more pathways for platelet aggregation.
Vargaftig BB; Chignard M; Le Couedic JP; Benveniste J
Acta Med Scand Suppl; 1980; 642():23-9. PubMed ID: 6779505
[No Abstract] [Full Text] [Related]
[Next] [New Search]
